CSI Market
Sign In | Register

Nanobiotix S a (NBTX) Annual Balance Sheets

Annual · GAAP · USD millions
Access NBTX quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Nanobiotix S a's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash And Cash Equivalents61.91
Cash & Short-term Investments61.00
Accounts receivable2.51
Other Current Assets8.81
Total Current Assets73.64
Equipment/Property/Plant Net5.36
Intangible Assets0.01
Other Assets, Noncurrent0.50
Other Current Assets8.81
Noncurrent Financial Assets-
Noncurrent Assets-
Noncurrent Financial Assets-
Noncurrent Financial Assets0.49
Noncurrent Assets5.61
Total Assets79.52
Liabilities
Accounts Payable10.70
Other Liabilities, Current64.28
Current Provisions0.14
Total Current Liabilities67.49
Total Long-term Debt0.00
Noncurrent Provisions106.10
Current Financial Liabilities4.83
Trade And Other Current Payables10.22
Other Current Liabilities8.32
Noncurrent Financial Liabilities101.93
Noncurrent Liabilities106.10
Total Liabilities178.67
Stockholders' Equity
Other Equity-94.62
Common Stockholder's Equity-94.62
Total Stockholder's Equity-94.62
Liabilities & Stockholder's Equity79.52
4 historic quarters locked

Sign in to unlock the full Nanobiotix S a balance sheet history.

Sign In Create Free Account

About Nanobiotix S A Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: March 31, 2026
  • Source: nbx-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001760854-26-000003

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License